References
- Costello M F. Polycystic ovary syndrome: a management update. Aust Fam Physician 2005; 34: 127–133
- Hassan A, Gordon C M. Polycystic ovary syndrome update in adolescence. Curr Opin Paediatr 2007; 19: 389–397
- Balen A. The pahophysiology of polycystic ovarian syndrome: trying to understand PCOS and its endocrinology. Best Pract Res Clin Obstet Gynaecol 2004; 18: 685–706
- Sharma A, Atiomo W. Recent development in polycystic ovarian syndrome. Curr Obstet Gynaecol 2003; 13: 281–286
- Stafford D EJ, Gordon C M. Adolescent androgen abnormalities. Curr Opin Obstet Gynaecol 2002; 14: 445–451
- Rosenfield R L. Clinical review: identifying children at risk for polycystic ovary syndrome. J Clin Endocrinol Metab 2007; 92: 787–796
- Herzog A G. Menstrual disorders in women with epilepsy. Neurology 2006; 66: S23–S28
- Fraser I S, Kovacs G. Current recommendation for the diagnostic evaluation and follow-up of patients presenting with symptomatic polycystic ovarian syndrome. Best Pract Res Clin Obstet Gynaecol 2004; 18: 813–823
- The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004; 19: 41–47
- Norman R J, Masters L, Milner C R, Wang J X, Daview M J. Relative risk of conversion from normoglycaemia to impaired glucose tolerance or non-insulin dependent diabetes mellitus in polycystic ovarian syndrome. Hum Reprod 2001; 16: 1995–1998
- Homburg R. Management of polycystic ovary syndrome in adolescence. Rev Gynaecol Pract 2004; 4: 148–155
- Bo-abbas Y Y, Brousseau V J, Louria D B, Benjamin S M, Valdez R, Vinicor F, Knowler W C. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393–403
- Norman R J, Davies M J, Lord J, Moran L J. The role of lifestyle modification in polycystic ovary syndrome. Trends Endocrinol Metab 2002; 13: 251–257
- Himelein M J, Thatcher S S. Polycystic ovary syndrome and mental health: a review. Obstet Gynaecol Surv 2006; 61: 723–732
- Ibáñez L, de Zegher F. Low-dose flutamide-metformin therapy for hyperinsulinemic hyperandrogenism in non-obese adolescents and women. Hum Reprod Update 2006; 12: 243–252
- Stener-Victorin E, Waldenstrom U, Tagnfors U, Lundeberg T. Effects of electro-acupuncture on anovulation in women with polycystic ovarian syndrome. Acta Obstet Gynecol Scand 2000; 79: 180–188
- Li X P. Chinese drugs of reinforcing kidney, clearing liver, and activating blood for treatment of infertility caused by polycystic ovary syndrome. J Fujian Coll Tradit Chin Med 2005; 15: 9–11
- Jin W X, Sun S X, Wang C Y. Research on Luole in treating female ovulatory disorder. J Fujian Coll Tradit Chin Med 1986; 10: 11–13
- Shao M X, Zhang X L, Sun J J, Yan L F. Clinical observation on TCM combined with western medicine in treating infertility caused by PCOS. J Sichuan Tradit Chin Med 2006; 24: 90–91
- Wang B Q, Ling M. Research development of Chinese herbal medicine for PCOS. Shandong J Tradit Chin Med 2008; 27: 138–140
- Tschugguel W, Berga S L. Treatment of functional hypothalamic amenorrhea with hypnotherapy. Fertil Steril 2003; 80: 982–985
- Steinback K. Adolescent overweight and obesity: how best to manage in the general practice setting. Aust Fam Physician 2007; 36: 606–612